X4 Pharmaceuticals, Inc.
Methods for treating cancer

Last updated:

Abstract:

The present invention relates to methods of treating patients with advanced forms of cancer, such as clear cell renal cell carcinoma, in which X4P-001 is administered in order to reduce angiogenic escape that typically occurs with TKI therapy. The methods demonstrate surprising results, including regression of tumor size and cell number, with comparatively little toxicity.

Status:
Grant
Type:

Utility

Filling date:

14 Dec 2016

Issue date:

23 Mar 2021